ETFsXtrackers Russell 2000 UCITS ETF 1C
Xtrackers
Xtrackers Russell 2000 UCITS ETF 1C
XRSU LSEAccumulatingIreland
Last close · EUR
373.35EUR
-2.21% · -€8.44
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
XRSUBase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- +17.4%
- Sharpe 3Y
- 0.72
- Volatility 1Y
- 15.4%annualised
- Holdings
- 1,972Fund holdings
Performance
Compare
- XRSU+17.4%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| XRSU | +1.5% | -0.9% | +6.2% | +18.9% | +17.4% | +64.9% | +33.2% |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.3% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | +1.1% | -5.7% | -4.6% | +2.6% | +1.6% | -10.6% | -38.1% |
Risk and return
Sharpe ratio · 3Y
0.72
Below MSCI World · 1.24- Return p.a.
- +16.2%
- Volatility
- 19.6%
- Max loss
- -32.3%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
XRSU
0.72
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 3.5%
- Holdings
- 1,972
- As of
- 1GLAUKOSUS37732210290.46%
- 2BRIGHTSPRING HEALTH SERVICES INCUS10950A10600.38%
- 3JFROGIL00116841850.34%
- 4TWIST BIOSCIENCEUS90184D10000.34%
- 5MOOG INC CLASS AUS61539420230.34%
- 6UMB FINANCIALUS90278810880.33%
- 7VIASAT INCUS92552V10080.33%
- 8SM ENERGYUS78454L10080.33%
- 9BRINKER INTERNATIONAL INCUS10964110040.31%
- 10RYMAN HOSPITALITY PROPERTIES REITUS78377T10790.30%
Countries
Classified 99.9%
United States94.9%
- Largest
- 94.9%United States
- Top 3
- 97.0%
- Effective number
- 1.11 / HHI
Market cap
Weight vs holdings
3.5%of the fund sits in the top 10 holdings
10.0%25.0%61.2%
WeightHoldings
1501,772
- Holdings 1-10
- Holdings 11-50
- Holdings 51-200
- Holdings 201+
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
